Marizyme, Inc. (MRZM) financial statements (2020 and earlier)

Company profile

Business Address 2295 TOWNE LAKE PKWY STE 116-290
WOODSTOCK, GA 30189
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
3/31/2018
12/31/2017
12/31/2012
12/31/2011
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 0001
Cash and cash equivalents 0001
Receivables    4
Prepaid expense 00 
Assets held-for-sale, not part of disposal group  00
Prepaid expense and other current assets0
Assets held-for-sale0
Income taxes receivable0
Other undisclosed current assets  000
Total current assets: 0006
Noncurrent Assets
Property, plant and equipment    0
Long-term investments and receivables    1
Long-term investments    0
Accounts and financing receivable, after allowance for credit loss    0
Intangible assets, net (including goodwill) 29  46
Goodwill    34
Intangible assets, net (excluding goodwill) 29  12
Prepaid expense and other noncurrent assets0
Assets held-for-sale, long lived2
Other undisclosed noncurrent assets  331
Total noncurrent assets: 293350
TOTAL ASSETS: 293357
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 00 6
Accounts payable  0  
Other undisclosed accounts payable and accrued liabilities 0  6
Debt    1
Due to related parties    3
Deferred revenue and credits  6
Other liabilities    1
Other undisclosed current liabilities  111
Total current liabilities: 01118
Noncurrent Liabilities
Long-term debt and lease obligation    4
Long-term debt, excluding current maturities    4
Liabilities, other than long-term debt    0
Pension and other postretirement defined benefit plans, liabilities0
Other undisclosed noncurrent liabilities    0
Total noncurrent liabilities:    4
Total liabilities: 01122
Stockholders' equity
Stockholders' equity attributable to parent, including: 292231
Common stock 0000
Treasury stock, value (0)(0)(0) 
Additional paid in capital 5830300
Accumulated other comprehensive income (loss)  (0)(1)0
Accumulated deficit (30)(28)(27)(19)
Other additional capital 000 
Other undisclosed stockholders' equity attributable to parent  0 50
Stockholders' equity attributable to noncontrolling interest    3
Total stockholders' equity: 292235
TOTAL LIABILITIES AND EQUITY: 293357

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
3/31/2018
12/31/2017
12/31/2012
12/31/2011
Revenues 0 026
Revenue, net  26
Other income   0
Cost of revenue (0)  (15)
Cost of goods and services sold    (15)
Other undisclosed gross profit   (0) 
Gross profit: 0 011
Operating expenses (0) (0)(20)
Other operating income (expense), net   (0)2
Other expenses   (1) 
Other undisclosed operating income (loss)   0(2)
Operating loss: (0) (0)(8)
Nonoperating expense (0)  (2)
Other nonoperating expense (0)  (1)
Interest and debt expense    (0)
Other undisclosed income from continuing operations before equity method investments, income taxes    0
Loss from continuing operations before equity method investments, income taxes: (0) (0)(10)
Loss from equity method investments    (0)
Loss from continuing operations before income taxes: (0) (0)(10)
Income tax expense    (1)
Loss before gain (loss) on sale of properties: (0) (0)(12)
Other undisclosed net income    0
Net loss: (0) (0)(11)
Other undisclosed net income (loss) attributable to parent   (0)5
Net loss available to common stockholders, diluted: (0) (1)(7)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
3/31/2018
12/31/2017
12/31/2012
12/31/2011
Net loss: (0) (0)(11)
Other undisclosed comprehensive loss    (0)
Comprehensive loss: (0) (0)(11)
Comprehensive loss, net of tax, attributable to noncontrolling interest    (0)
Other undisclosed comprehensive income, net of tax, attributable to parent    5
Comprehensive loss, net of tax, attributable to parent: (0) (0)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: